Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Pharma Blogs:
The Science Business
Org Prep Daily
Kilomentor
On Pharma
Kinase Pro
Chemical Quantum Images
One in Ten Thousand
Periodic Tabloid
Chemical Musings
C&E News Blog
Noel O'Blog
In Vivo Blog
Chirality
BBSRC/Douglas Kell
Drug Discovery Opinion
The Chemblog
Realizations in Biostatistics
Molecule of the Day
Chemjobber
WSJ Health Blog
PK/PD
Social Detritus
ChemSpider Blog
Pharmagossip
Organometallic Current
Useful Chemistry
Great Molecular Crapshoot
No Name No Slogan
Post Doc Ergo Propter Doc
SimBioSys
Culture of Chemistry
The Curious Wavefunction
Chemical Sabbatical
Totally Synthetic
Molecular Philosophy
Zusammen
Pharma's Cutting Edge
My Chemical Journey
The F- Blog
Chemical Professionals
Generally Chemistry
Chemistry World Blog
Eigenfunction/Eigenvalue
Synthesizing Ideas
Carbon-Based Curiosities
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Peter Murray-Rust
Chemical Forums
Depth-First
Curly Arrow
ChemCafe
Power of Goo
Fetz the Chemist
Carbon Tet
Chemical Crosspatch
Sceptical Chymist
Atomchuxky
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa
Making Graphite Work
Realm of Organic Synthesis
Liquid Carbon
Pharma Blog Review


Science Blogs and News:
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Life of a Lab Rat
Nobel Intent
SciTech Daily
Is This Thing On?
Science Blog
Eastern Blot
FuturePundit
Flags and Lollipops
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Terra Sigillata
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Living the Scientific Life
Humans in Science
Speculist
Science, Shrimp and Grits
Cosmic Variance
The Capsule
Zeroth Order Approximation
Science Library Blog
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Boston area?: Join us on June 11 for Startups and the Cloud, a free event on cloud computing with insights from Intuit founder Scott Cook and others

In the Pipeline

« Why Pfizer? | Main | Things I Won't Work With: Azidotetrazolate Salts »

January 7, 2009

New Chemistry

Email This Entry

Posted by Derek

So I see that Nature Chemistry looks to be fueling up to launch. I’m curious to see how that one will do. The other Nature journals have done pretty well at preserving the prestige of the name, but I hope that they haven’t reached the point of diminishing returns just when they get to my specialty.

And this will be unusual, since you don’t see many attempts to launch a high-end journal from scratch. Most new journals aim for the middle (or worse), figuring that that’s where the papers will come from. But Nature Chemistry will presumably try to compete with JACS and Angewandte Chemie. My guess is that they’ll be able to do that, which means that the journals one tier down will be the ones that feel the consequences. On the other hand, it’s not like Nature has a reputation for paying much attention to chemistry over the years, so perhaps the cachet won’t carry over in the same way that it did for, say, Nature Medicine. We shall see. . .

Comments (2) + TrackBacks (0) | Category: The Scientific Literature


COMMENTS

1. anon on January 7, 2009 2:36 PM writes...

JACS, high end? Not in recent decades. Lots of nanocrap.


And I think the ACS spends all their publication budget on making the on-line access pages ever more confusing.

I'll check out Nature Chemistry. Could be good.

Permalink to Comment

2. eugene on January 7, 2009 7:47 PM writes...

Really, competing with JACS and Andjewandte? What about Chem. Comm.? I'm writing up something for, I think Chem. Comm., but I noticed this Nature Chemistry journal, and was thinking about submitting there. Looks like they'll scoff at me if what you say is true. Although, I suppose this paper could be accepted at JACS on an off day.

I'm guessing I shouldn't try for the first few issues of Nature Chemistry anyways.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Short Items: India, Sanjay Gupta, Satori Pharmaceuticals
Things I Won't Work With: Azidotetrazolate Salts
New Chemistry
Why Pfizer?
Pharmalot Is No More
Well, Hose Me Down. . .
New Year - I Hope!
Holiday Break